19.51 USD
+0.17 (+0.88%)
19.51 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 76% to SBRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.17. This target is 8.48% above the current price.
SBRA was analyzed by 20 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SBRA.
In the previous month the buy percentage consensus was at a similar level.
SBRA was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-18 | UBS | Initiate | Neutral |
| 2025-10-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-01 | Cantor Fitzgerald | Initiate | Neutral |
| 2025-09-03 | Truist Securities | Maintains | Hold -> Hold |
| 2025-08-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-25 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-08-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-23 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-05-12 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-21 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-17 | Truist Securities | Downgrade | Buy -> Hold |
| 2025-01-07 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2024-12-05 | Mizuho | Downgrade | Outperform -> Neutral |
| 2024-10-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-09-13 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-09-04 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-26 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-06-27 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-15 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-01-30 | Deutsche Bank | Initiate | Buy |
| 2024-01-03 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-07 | Stifel | Maintains | Buy -> Buy |
| 2023-10-17 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2023-10-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-16 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2023-10-10 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-10-03 | Wedbush | Initiate | Outperform |
| 2023-09-20 | Jefferies | Upgrade | Hold -> Buy |
SABRA HEALTH CARE REIT INC / SBRA FAQ
What is the average price target for SABRA HEALTH CARE REIT INC (SBRA) stock?
20 analysts have analysed SBRA and the average price target is 21.17 USD. This implies a price increase of 8.48% is expected in the next year compared to the current price of 19.51.
What is the consensus rating for SBRA stock?
The consensus rating for SABRA HEALTH CARE REIT INC (SBRA) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.